Chromatin Regulation of KSHV Primary Infection
Chromatin Regulation of KSHV Primary Infection
批准号:
8541139
负责人:
PAUL M LIEBERMAN
金额:
$40.17万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-05-08 至 2018-04-30
关键词:
Antiviral AgentsB-LymphocytesBinding SitesCSPG6 geneCell divisionCellsChromatinChromatin ModelingChromatin StructureChromosome StructuresChromosomesDAXX geneDNADataDiseaseEndothelial CellsEnvironmentEpigenetic ProcessEquilibriumEventGene ExpressionGenetic TranscriptionGenomeGenome StabilityHumanHuman Herpesvirus 8Immediate-Early GenesImmediate-Early ProteinsInfectionInstructionKaposi SarcomaLymphomaLyticMaintenanceMalignant NeoplasmsMediatingMethodsModificationMolecularMolecular ConformationMulticentric Angiofollicular Lymphoid HyperplasiaPatternPlayPleural effusion disorderProteinsPublishingRegulationRoleSiteStagingTherapeutic InterventionTranscriptional RegulationViralViral GenesWorkchromatin remodelingcohesincohesionconnective tissue growth factordriving forceepigenomegammaherpesvirusgenome-widehistone modificationinsightlatent infectionprogramstransmission processvirus host interaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
(See instructions):
KSHV is a human gammaherpesvirus that is the causative agent of Kaposi's sarcoma (KS), and tightly associated with pleural effusion lymphoma (PEL) and multicentric Castleman's disease (MCD). Establishment of latent infection in B-lymphocytes and persistent infection in endothelial cells is thought to be a major driving force for KSHV-associated disease. Establishment of latent infection requires the formation of a stable circular minichromosome that expresses a limited set of viral genes. The mechanisms that establish minichromosome formation and restrict gene expression to the latency class are not well understood. Our previously published studies indicate that chromatin boundary factors, like CTCF, organize viral chromosome structure and histone modification patterns important for genome stability and restricted gene expression. CTCF interacts with cohesins (e.g. SMCl, SMC3, Rad21) to form higher order DNA conformations that are important for chromosome transmission during cell division and for coordinated transcription regulation. Recent studies from our group revealed that CTCF-cohesins mediate Interactions between the latent and lytic control regions of KSHV genomes in latently infected PEL cells. New preliminary data indicate that lytic immediate early genes are coordinately regulated through a chromatin structure involving CTCF and cohesins, and that cohesins are required for suppression of lytic gene transcription. Furthermore, CTCF binding sites are located in close proximity to RBP-jK sites at the lytic and latent control regions. Since RBP-jK is a primary target of KSHV immediate early protein Rta and latency maintenance protein LANA, we will explore how these proteins (e.g. RBP-jK, Rta, K8, and LANA) may interact with arid regulate CTGF-cohesion function. We will also investigate the role of host intrinsic defense proteins in regulating viral chromatin assembly. Finally, we will explore the role of LANA and KSHV infection on viral and host chromosome structure and epigenetic: modifications. These aims will synergize with projects 1 & 2 of this program project, and provide both molecular and genome-wide analyses of chromatin control mechanisms during the early stages of KSHV infection and in the establishment of KSHV latency
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 4: Regulation of EBV Latency and Oncogenesis by Hypoxia
-
批准号:10714176
-
项目类别:
-
资助金额:$47.49万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Epigenomic Drivers of EBV Epithelial Cancers
-
批准号:10627690
-
项目类别:
-
资助金额:$46.97万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
-
批准号:10627689
-
项目类别:
-
资助金额:$243.61万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
EBNA1 Inhibitor for Treatment of EBV-positive DLBCL
-
批准号:10719866
-
项目类别:
-
资助金额:$74.58万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Administrative and Biostatistics
-
批准号:10627693
-
项目类别:
-
资助金额:$15.99万
-
财政年份:2023
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Epigenetic Regulation of Epstein-Barr Virus
-
批准号:10363894
-
项目类别:
-
资助金额:$36.46万
-
财政年份:2022
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Epigenetic Regulation of Epstein-Barr Virus
-
批准号:10550255
-
项目类别:
-
资助金额:$36.46万
-
财政年份:2022
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Drugging EBNA1 to Treat EBV-Associated Cancers - Diversity Supplement
-
批准号:10818976
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2021
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Drugging EBNA1 to Treat EBV-Associated Cancers
-
批准号:10185459
-
项目类别:
-
资助金额:$58.25万
-
财政年份:2021
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Regulation of EBV Latency by Purine Metabolism and Signaling
-
批准号:10298045
-
项目类别:
-
资助金额:$45.76万
-
财政年份:2021
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Regulation of EBV Latency by Purine Metabolism and Signaling
-
批准号:10407656
-
项目类别:
-
资助金额:$45.76万
-
财政年份:2021
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Development of a Small Molecule Inhibitor for KSHV LANA
-
批准号:8856529
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Development of a Small Molecule Inhibitor for KSHV LANA
-
批准号:8732352
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Development of a Small Molecule Inhibitor for KSHV LANA
-
批准号:9057999
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2014
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Chromatin Regulation of KSHV Primary Infection
-
批准号:8874167
-
项目类别:
-
资助金额:$15.52万
-
财政年份:2013
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Purchase of a Biacore T200 Surface Plasmon Resonance Label-free Detection System
-
批准号:8447935
-
项目类别:
-
资助金额:$36.73万
-
财政年份:2013
-
负责人:PAUL M LIEBERMAN
-
依托单位:
ChIP Sequencing Core
-
批准号:8874170
-
项目类别:
-
资助金额:$12.55万
-
财政年份:2013
-
负责人:PAUL M LIEBERMAN
-
依托单位:
ChIP Sequencing Core
-
批准号:8541143
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2013
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Conference Support for International Congress on Oncogenic Herpesviruses
-
批准号:8400154
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2012
-
负责人:PAUL M LIEBERMAN
-
依托单位:
Development of a Small Molecule Inhibitor for EBV Latent Infection
-
批准号:8781640
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2012
-
负责人:PAUL M LIEBERMAN
-
依托单位:
海外基金